Fingerprint
Dive into the research topics where Shlomo Almog is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn's Disease, a Randomised Controlled Trial
Naftali, T., Bar-Lev Schleider, L., Almog, S., Meiri, D. & Konikoff, F. M., 1 Nov 2021, In: Journal of Crohn's and Colitis. 15, 11, p. 1799-1806 8 p.Research output: Contribution to journal › Article › peer-review
53 Scopus citations -
The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial
Almog, S., Aharon-Peretz, J., Vulfsons, S., Ogintz, M., Abalia, H., Lupo, T., Hayon, Y. & Eisenberg, E., 1 Sep 2020, In: European Journal of Pain (United Kingdom). 24, 8, p. 1505-1516 12 p.Research output: Contribution to journal › Article › peer-review
Open Access77 Scopus citations -
The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: A phase 1a study
Eisenberg, E., Ogintz, M. & Almog, S., Sep 2014, In: Journal of Pain and Palliative Care Pharmacotherapy. 28, 3, p. 216-225 10 p.Research output: Contribution to journal › Article › peer-review
83 Scopus citations -
Human biomonitoring in Israel: Past, present, future
Berman, T., Amitai, Y., Almog, S. & Richter, E. D., Feb 2012, In: International Journal of Hygiene and Environmental Health. 215, 2, p. 138-141 4 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations -
Severe paramethoxymethamphetamine (PMMA) and paramethoxyamphetamine (PMA) outbreak in Israel
Lurie, Y., Gopher, A., Lavon, O., Almog, S., Sulimani, L. & Bentur, Y., Jan 2012, In: Clinical Toxicology. 50, 1, p. 39-43 5 p.Research output: Contribution to journal › Article › peer-review
28 Scopus citations